HIGHLIGHTS
- What: This study has demonstrated that the higher serum transgelin on admission was, the higher risk of poor prognosis during hospitalization was. Although this study has hinted that serum transgelin expression may be regarded as a biomarker for monitoring the severity and prognosis among CVOID-19 patients.
- Who: . and collaborators from the University of Nebraska-Lincoln, United States have published the research work: Serum transgelin is a novel prognostic biomarker for COVID-19 patients, in the Journal: (JOURNAL)
- How: This research may provide an important clue about the application which was used as . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.